AzTrials
AzTrials

Acute Kidney InjuryNCT04948710

Sonographic Venous Doppler Imaging in Acute Kidney Injury

An observational study of Acute Kidney Injury, run by Gazi University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The first presentations of patients with acute kidney injury (AKI) are usually to the emergency departments. While the mortality rate is 5-10% in uncomplicated AKI, it is between 40-90% in patients hospitalized in the intensive care unit. Read more about this study

Who is it for?
Ages 18 to 110 years
Conditions the study is for
Acute Kidney Injury
What is being tested?
Sonography
How many people
150 participants
Where
1 siteTurkey (Türkiye)
Study dates
25 Jun 2021to 25 Oct 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 110 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Emergency department patients with acute kidney injury

Who may be able to join

  • AKI diagnosis

Who cannot join

  • Patients
  • with end-stage renal failure (stage 4),
  • who received 500 mL IV fluid or 40 mg diuretics,
  • who are pregnant,
  • with renal transplantation,
  • with cirrhosis and liver malignancy,
Show all 9Show fewer
  • with postrenal AKI,
  • who were referred from another center after starting treatment,
  • who do not give consent for the study.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Gazi University Facaulty of Medicine

    Ankara

Other trials in Turkey (Türkiye)

About this study

Official title: Diagnostic Accuracy of Sonographic Venous Doppler Imaging in Acute Kidney Injury

The first presentations of patients with acute kidney injury (AKI) are usually to the emergency departments. While the mortality rate is 5-10% in uncomplicated AKI, it is between 40-90% in patients hospitalized in the intensive care unit. Therefore early diagnosis and treatment of AKI in the emergency department is important in terms of morbidity and mortality.

Sonographic evaluation of the venous system (hepatic, portal and renal vein) may be useful for diagnosis. Studies conducted so far have generally been based on predicting cardiorenal AKI and renal poor outcomes and have been designed in general ICU conditions.

In this study, the investigators aimed to determine the diagnostic value of sonographic venous Doppler imaging in terms of distinguishing subgroups of AKI in patients presented to the emergency department with AKI.

Being tested
Sonography
Medical subject headings
Acute Kidney Injury

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • SonographyDiagnostic test

    Sonographic Venous Doppler Imaging

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The diagnostic accuracy of sonographic venous Doppler imaging in the patients with AKI

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Jul 2021
  2. Study start25 Jun 2021
  3. Primary completion25 Oct 2022
  4. Study completion25 Oct 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
150 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04948710
Sponsor's protocol ID
GaziUniv
Status last verified
Jan 2023
First submitted
28 Jun 2021
Last updated
31 Jan 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Aslaner MA, Helvaci O, Haycock K, Kilicaslan I, Yasar E, Cerit MN, Sendur HN, Guz G, Demircan A. Diagnostic accuracy of venous system ultrasound for subtypes of acute kidney injury. Emerg Med J. 2024 Apr 22;41(5):304-310. doi: 10.1136/emermed-2023-213241.

    PubMed 38355289

Questions about this trial

What is this clinical trial studying?

An observational study of Acute Kidney Injury, run by Gazi University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 31 Jan 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The diagnostic accuracy of sonographic venous Doppler imaging in the patients with AKI (time frame: 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04948710, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Jan 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in